At March 31, 2019 and September 30, 2018, the Company’s Canadian subsidiary had CAN$14.3 million and CAD$20.4 million, respectively, of Canadian dollar denominated intercompany accounts payable owed to one of the Company’s U.S subsidiaries. In order to mitigate its exposure to movements in foreign currency rates between the U.S. dollar and Canadian dollar, the Company routinely enters into foreign currency forward contracts to hedge a portion of its exposure to changes in the value of the Canadian dollar. On March 29, 2019, the Company entered into a CAD$10.0 million 90-day hedge contract with a United States bank to reduce the impact on cash flows from movements in the Canadian dollar/U.S. dollar currency exchange rate, but has not been designated as a hedge for accounting purposes.

The following table summarizes the gross fair value of all derivative instruments, which are not designated as hedging instruments and their location in the consolidated balance sheets (in thousands).

Derivative Instrument		Location		March 31, 2019				September 30, 2018
Foreign Currency Forward Contracts		Accrued Expenses and Other Current Liabilities		$	41			$	270

The following table summarizes the Company’s realized gains on derivative instruments included in the consolidated statements of operations for the three and six months ended March 31, 2019 and 2018 (in thousands):

		Three Months Ended				Six Months Ended
Derivative Instrument	Location	March 31, 2019		March 31, 2018		March 31, 2019		March 31, 2018
Foreign Currency Forward Contracts	Other Income (Expense)	$	217	$	733	$	639	$	575